There are two phase 1 and 2 clinical trials reporting about a new PSMA targeting alpha emitting investigational radiation treatment. The trials are are very promising. They evaluate a new investigational treatment called Ac-225-PSMA-617.
We now need to wait for a phase 3 trial.